SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-20-019737
Filing Date
2020-02-13
Accepted
2020-02-13 08:32:49
Documents
1
Group Members
JEROME G. PFUNDMICHAEL L. SJOSTROM

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A tm207545-1_sc13ga.htm SC 13G/A 75335
  Complete submission text file 0001104659-20-019737.txt   76905
Mailing Address 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121
Business Address 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Subject) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-44849 | Film No.: 20607131
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1010 SHERBROOKE ST., WEST SUITE 1610 MONTREAL A8 H3A 2R7
Business Address 1010 SHERBROOKE ST., WEST SUITE 1610 MONTREAL A8 H3A 2R7 514 849 8777
SECTORAL ASSET MANAGEMENT INC (Filed by) CIK: 0001274413 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8
Type: SC 13G/A